LeMaitre Vascular, Inc. (LMAT) 2022年年度报告「NASDAQ」.pdf

《LeMaitre Vascular, Inc. (LMAT) 2022年年度报告「NASDAQ」.pdf》由会员分享，可在线阅读，更多相关《LeMaitre Vascular, Inc. (LMAT) 2022年年度报告「NASDAQ」.pdf（100页珍藏版）》请在三个皮匠报告上搜索。

1、2022 ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington,D.C.20549 FORM 10-K (Mark One)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31,2022 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECUR

2、ITIES EXCHANGE ACT OF 1934 For the transition period from to .Commission File Number 001-33092 LEMAITRE VASCULAR,INC.(Exact name of registrant as specified in its charter)Delaware 04-2825458(State or other jurisdiction of incorporation or organization)(I.R.S.Employer Identification No.)63 Second Ave

3、nue,Burlington,Massachusetts 01803(Address of principal executive offices)(Zip Code)Registrants telephone number,including area code 781-221-2266 Securities registered under Section 12(b)of the Act:Title of each class Trading symbol Name of exchange on which registered Common stock,$0.01 par value p

4、er share LMAT The Nasdaq Global Market Securities registered pursuant to Section 12(g)of the Act:None Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes:No:Indicate by check mark if the registrant is not required to file reports

5、pursuant to Section 13 or Section 15(d)of the Act.Yes:No:Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the registrant was required

6、to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes:No:Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during t